Please login to the form below

Not currently logged in
Email:
Password:

Glassia

This page shows the latest Glassia news and features for those working in and with pharma, biotech and healthcare.

Shire receives FDA nod for self-infusion of Glassia

Shire receives FDA nod for self-infusion of Glassia

Shire receives FDA nod for self-infusion of Glassia. The company has also struck a deal with Pfizer to expand its GI portfolio. ... Shire's emphysema therapy Glassia has received FDA approval for an expanded label, marking the first time that patients

Latest news

  • Scratching the surface

    UK. Alpha-1 proteinase inhibitor. Glassia (Baxter International). Overt hepatic encephalopathy (HE) recurrence.

  • Biologics buoyant

    52 . Kamada/Baxter. Glassia (liquid Alpha-1 Antitrypsin; AAT) – AAT deficiency (US, Canada, Australia and New Zealand).

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics